Related Experiment Video

Updated: Apr 25, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

TIP30 nuclear translocation negatively regulates EGF-dependent cyclin D1 transcription in human lung adenocarcinoma

Shuai Shuai1, Xiao Yan2, Junyi Zhang1

  • 1Cancer Center, Traditional Chinese Medicine-Integrated Hospital, Southern Medical University, Guangzhou, Guangdong 510315, China.

Cancer Letters
|August 20, 2014
PubMed

Insights

Tumor suppressor TIP30 moves to the nucleus in lung cancer cells after epidermal growth factor (EGF) exposure. Nuclear TIP30 inhibits cyclin D1 transcription, counteracting EGF signaling and suppressing tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Aberrant epidermal growth factor (EGF) signaling drives human carcinoma progression.
  • EGF receptor (EGFR) pathway dysregulation is implicated in lung adenocarcinoma.
  • Understanding molecular mechanisms that suppress EGFR signaling is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the role of the tumor suppressor TIP30 in regulating EGF-dependent signaling in lung adenocarcinoma.
  • To elucidate the mechanism by which TIP30 affects CCND1 transcription.
  • To determine the clinical relevance of TIP30 and EGFR in lung adenocarcinoma patients.

Main Methods:

  • Cellular localization studies of TIP30 in response to EGF treatment.
  • Pharmacological inhibition of EGFR signaling pathways.
  • Chromatin immunoprecipitation (ChIP) assays to assess TIP30 binding and transcriptional regulation.
  • Correlation analysis of nuclear TIP30, EGFR, and cyclin D1 levels in patient samples.

Main Results:

  • TIP30 translocates to the nucleus in lung adenocarcinoma cells upon EGF stimulation.
  • EGFR signaling inhibitors block TIP30 nuclear translocation.
  • TIP30 negatively regulates EGF-induced CCND1 transcription via a HDAC1-dependent mechanism.
  • Nuclear TIP30 levels are inversely correlated with EGFR and cyclin D1 expression in lung adenocarcinoma patients.

Conclusions:

  • Nuclear TIP30 acts as a negative regulator of EGFR signaling in lung adenocarcinoma.
  • TIP30-mediated downregulation of cyclin D1 transcription suppresses tumorigenesis.
  • TIP30 represents a potential therapeutic target for counteracting EGFR-driven lung cancers.
Keywords:
Cyclin D1EGFRHDAC1Lung adenocarcinomaTIP30

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

6.0K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K